Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine/enalapril

CONCLUSIONS: Lercanidipine may be regarded as an ideal antihypertensive drug for patients at renal risk and possibly the preferred choice among calcium channel blocker drugs.PMID:36314318 | DOI:10.26355/eurrev_202210_30018

Source: European Review for Medical and Pharmacological Sciences - October 31, 2022 Category: Drugs & Pharmacology Authors: N Ferri A Corsini R Pontremoli Source Type: research